 |
|
Timeliness and Quality of Care for Elderly Patients With Acute Myocardial Infarction Under Health Maintenance Organization vs Fee-for-Service Insurance
Stephen B. Soumerai, ScD;
Thomas J. McLaughlin, ScD;
Jerry H. Gurwitz, MD;
Steven Pearson, MD;
Cindy L. Christiansen, PhD;
Catherine Borbas, PhD;
Nora Morris, MA;
Barbara McLaughlin, BAN;
Xiaoming Gao, MA;
Dennis Ross-Degnan, ScD
Arch Intern Med. 1999;159:2013-2020.
Background A commonly voiced concern is that health maintenance organizations (HMOs) may withhold or delay the provision of urgent, essential care, especially for vulnerable patients like the elderly.
Objective To compare the quality of emergency care provided in Minnesota to elderly patients with acute myocardial infarction (AMI) who are covered by HMO vs fee-for-service (FFS) insurance.
Methods We reviewed the medical records of 2304 elderly Medicare patients who were admitted with AMI to 20 urban community hospitals in Minnesota (representing 91% of beds in areas served by HMOs) from October 1992 through July 1993 and from July 1995 through April 1996.
Main Outcome Measures Use of emergency transportation and treatment delay (>6 hours from symptom onset); time to electrocardiogram; use of aspirin, thrombolytics, and  -blockers among eligible patients; and time from hospital arrival to thrombolytic administration (door-to-needle time).
Results Demographic characteristics, severity of symptoms, and comorbidity characteristics were almost identical among HMO (n=612) and FFS (n=1692) patients. A cardiologist was involved as a consultant or the attending physician in the care of 80% of HMO patients and 82% of FFS patients (P=.12). The treatment delay, time to electrocardiogram, use of thrombolytic agents, and door-to-needle times were almost identical. However, 56% of HMO patients and 51% of FFS patients used emergency transportation (P=.02); most of this difference was observed for patients with AMIs that occurred at night (60% vs 52%; P=.02). Health maintenance organization patients were somewhat more likely than FFS patients to receive aspirin therapy (88% vs 83%; P=.03) and -blocker therapy (73% vs 62%; P=.04); these differences were partly explained by a significantly larger proportion of younger physicians in HMOs who were more likely to order these drug therapies. All differences were consistent across the 3 largest HMOs (1 staff-group model and 2 network model HMOs). Logistic regression analyses controlling for demographic and clinical variables produced similar results, except that the differences in the use of -blockers became insignificant.
Conclusions No indicators of timeliness and quality of care for elderly patients with AMIs were lower under HMO vs FFS insurance coverage in Minnesota. However, two indicators of quality care were slightly but significantly higher in the HMO setting (use of emergency transportation and aspirin therapy). Further research is needed in other states, in different populations, and for different medical conditions.
From the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass (Drs Soumerai, McLaughlin, Pearson, Christiansen, and Ross-Degnan and Ms Gao); the Meyers Primary Care Institute, Fallon Healthcare System, and the University of Massachusetts Medical School, Worcester (Dr Gurwitz); and the Healthcare Education and Research Foundation, St Paul, Minn (Dr Borbas and Mss Morris and McLaughlin).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(17):2094-2095.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Health Effects of Managed Care Among the Near-Elderly
Xu and Jensen
J Aging Health 2006;18:507-533.
ABSTRACT
Primary Care Quality
Weissberg et al.
Arch Intern Med 2002;162:2493-2494.
FULL TEXT
HMO Plan Performance Update: An Analysis Of The Literature, 1997-2001
Miller and Luft
Health Aff (Millwood) 2002;21:63-86.
ABSTRACT
| FULL TEXT
Medication Decisions--Right and Wrong
Stuart and Briesacher
Med Care Res Rev 2002;59:123-145.
ABSTRACT
Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction
Phillips et al.
JAMA 2000;284:2748-2754.
ABSTRACT
| FULL TEXT
|
